Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q3 FY2020
As of Sep 30, 2020
Q2 FY2020
As of Jun 30, 2020
Q1 FY2020
As of Mar 31, 2020
Q4 FY2019
As of Dec 31, 2019
Assets
Current assets
Cash and cash equivalents
Prepaid expenses
Restricted cash, current
Inventory
Prepaids and other current assets
Derivative asset
Total current assets
Property and equipment, net
Restricted cash, non-current
Operating lease right-of-use assets
Deferred warrant asset
Deferred battery supplier cost, non-current
Other non-current assets
Total assets
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
Accrued expenses and other current liabilities
Convertible debt, current
Derivative liability, current
Financing liability, current
Warrant liability, current
Total current liabilities
Contingent earnout shares liability
Private placement warrants liability
Operating lease liabilities, non-current
Convertible debt, non-current
Derivative liability, non-current
Financing liability, non-current
Warrant liability, non-current
Other liabilities
Total liabilities
Redeemable preferred stock, $0.0001 par value; 10,000 authorized, 62 and 45 shares issued and outstanding as of September 30, 2024, and December 31, 2023, respectively.
Stockholders’ equity
Common stock, $0.0001 par value; 2,000,000 authorized as of September 30, 2024 and December 31, 2023, respectively; 72,902 and 37,591 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
Total common stock, $0.0001 par value; 2,000,000 authorized as of September 30, 2024 and December 31, 2023, respectively; 72,902 and 37,591 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively
Additional paid-in capital
Accumulated deficit
Preferred stock and stockholders’ equity
Total preferred stock and stockholders’ equity
Total liabilities, preferred stock and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support